This inventor holds 1 USPTO granted patent. Top assignee: The Procter Gamble Company. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovations of Robert Arthur Lyon
Introduction
Robert Arthur Lyon is an accomplished inventor based in Milford, OH (US). He has made significant contributions to the field of medicine, particularly in the treatment of diseases mediated by inflammatory cytokines. His innovative work has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Lyon holds a patent for 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones, which are designed to control inflammatory cytokines. This invention relates to methods for treating diseases or disease states that are affected by the extracellular release of cytokines. The method involves administering one or more of the 6,7-dihydro-5H-pyrazolo[1,2a]pyrazol-1-ones to a human or higher mammal in need of treatment.
Career Highlights
Lyon is associated with The Procter & Gamble Company, where he has been able to apply his expertise in developing innovative solutions for health-related challenges. His work has not only contributed to the company's portfolio but has also had a positive impact on public health.
Collaborations
Lyon has collaborated with Michael Philip Clark, a fellow innovator, to further enhance the research and development of their projects. Their partnership exemplifies the importance of teamwork in the field of innovation.
Conclusion
Robert Arthur Lyon's contributions to the field of medicine through his patent for 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones highlight his commitment to improving health outcomes. His work continues to inspire future innovations in the treatment of diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile